blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1631591

EP1631591 - CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.10.2012
Database last updated on 13.07.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
FIBROGEN, INC.
409 Illinois Street
San Francisco, CA 94158 / US
[2011/10]
Former [2006/10]For all designated states
FIBROGEN, INC.
225 Gateway Boulevard
South San Francisco, CA 94080 / US
Inventor(s)01 / LIN, Ai, Y.
7884 Pineville Circle
Castro Valley, CA 94552 / US
02 / NEFF, Thomas, B.
190 Glenwood Avenue
Atherton, CA 94027 / US
03 / OLIVER, Noelynn, A.
421 Mundel Way
Los Altos, CA 94022 / US
04 / USINGER, William, R.
1056 Roderick Court
Lafayette, CA 94549 / US
05 / WANG, Qingjian
37 Edgewood Place
Belmont, CA 94002 / US
06 / YEOWELL, David, A.
2432 Diamond Street
San Francisco, CA 94131 / US
 [2006/10]
Representative(s)Goodfellow, Hugh Robin, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2008/46]Goodfellow, Hugh Robin, et al
Carpmaels & Ransford, 43-45 Bloomsbury Square London
WC1A 2RA / GB
Former [2006/10]Goodfellow, Hugh Robin, et al
Carpmaels & Ransford, 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date04753822.802.06.2004
[2006/10]
WO2004US17080
Priority number, dateUS20030475598P04.06.2003         Original published format: US 475598 P
US2004085818601.06.2004         Original published format: US 858186
[2006/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004108764
Date:16.12.2004
Language:EN
[2004/51]
Type: A2 Application without search report 
No.:EP1631591
Date:08.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 16.12.2004 takes the place of the publication of the European patent application.
[2006/10]
Type: B1 Patent specification 
No.:EP1631591
Date:21.12.2011
Language:EN
[2011/51]
Search report(s)International search report - published on:EP05.01.2006
ClassificationIPC:C07K16/22
[2006/10]
CPC:
C07K16/22 (EP,KR,US); A61K39/395 (KR); A61P1/16 (EP);
A61P11/00 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P19/02 (EP); A61P19/04 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07K16/00 (KR); A61K2039/505 (EP,US); C07K2317/21 (EP,US);
C07K2317/24 (US); C07K2317/31 (US); C07K2317/32 (EP);
C07K2317/35 (US); C07K2317/41 (US); C07K2317/54 (US);
C07K2317/55 (US); C07K2317/622 (US); C07K2317/76 (EP,US);
C07K2317/92 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/10]
Extension statesAL27.12.2005
HR27.12.2005
LT27.12.2005
LV27.12.2005
MK27.12.2005
TitleGerman:ANTIKÖRPER GEGEN CONNECTIVE TISSUE GROWTH FACTOR[2006/10]
English:CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES[2006/10]
French:ANTICORPS DIRIGES CONTRE LE FACTEUR DE CROISSANCE DU TISSU CONJONCTIF[2006/10]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase27.12.2005National basic fee paid 
27.12.2005Designation fee(s) paid 
27.12.2005Examination fee paid 
Examination procedure04.04.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.12.2005Amendment by applicant (claims and/or description)
27.12.2005Examination requested  [2006/10]
12.07.2007Despatch of a communication from the examining division (Time limit: M06)
18.01.2008Reply to a communication from the examining division
27.06.2008Observations by third parties
06.08.2008Despatch of a communication from the examining division (Time limit: M04)
17.11.2008Reply to a communication from the examining division
14.12.2009Despatch of a communication from the examining division (Time limit: M02)
24.02.2010Reply to a communication from the examining division
28.05.2010Communication of intention to grant the patent
12.11.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
12.01.2011Fee for grant paid
12.01.2011Fee for publishing/printing paid
Divisional application(s)EP10184591.5  / EP2322549
EP10184854.7  / EP2338914
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.07.2007
Opposition(s)24.09.2012No opposition filed within time limit [2012/48]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
12.01.2011Request for further processing filed
12.01.2011Full payment received (date of receipt of payment)
Request granted
11.02.2011Decision despatched
Fees paidRenewal fee
27.12.2005Renewal fee patent year 03
08.06.2007Renewal fee patent year 04
18.03.2008Renewal fee patent year 05
05.06.2009Renewal fee patent year 06
11.06.2010Renewal fee patent year 07
11.08.2011Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.06.201108   M06   Fee paid on   11.08.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.06.2004
CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
FI02.06.2012
LU02.06.2012
ES03.06.2012
MC30.06.2012
[2014/34]
Former [2014/27]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
FI02.06.2012
LU02.06.2012
ES03.06.2012
MC30.06.2012
Former [2014/21]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
FI02.06.2012
ES03.06.2012
MC30.06.2012
Former [2013/48]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
FI02.06.2012
ES03.06.2012
MC30.06.2012
Former [2013/09]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
FI02.06.2012
MC30.06.2012
Former [2013/08]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
MC30.06.2012
Former [2012/37]CY21.12.2011
CZ21.12.2011
EE21.12.2011
PL21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
GR22.03.2012
PT23.04.2012
Former [2012/36]CY21.12.2011
CZ21.12.2011
EE21.12.2011
RO21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
GR22.03.2012
Former [2012/35]CY21.12.2011
CZ21.12.2011
EE21.12.2011
SI21.12.2011
BG21.03.2012
GR22.03.2012
Former [2012/34]CY21.12.2011
CZ21.12.2011
SI21.12.2011
GR22.03.2012
Former [2012/28]CY21.12.2011
SI21.12.2011
GR22.03.2012
Former [2012/24]SI21.12.2011
GR22.03.2012
Cited inInternational search[X]WO9913910  (JAPAN TOBACCO INC [JP], et al) [X] 1-26,29,51-79 * abstract *;
 [XDI]WO0035936  (UNIV MIAMI [US], et al) [XD] 1-10,12-15,17-19,21,26,29,51-58,60-64,66-71,73-79 * page 4, line 15 - line 21 * * page 5, line 4 - line 5 * * page 26, line 7 - page 29, line 22 * * page 55, line 1 - page 56, line 14 * [I] 11,16,20,22-25,59;
 [X]EP1043335  (JAPAN TOBACCO INC [JP], et al) [X] 1-26,29,51-79 * page 41, paragraph 342 - paragraph 346 * * figure 2 *;
 [PDA]WO03049773  (FIBROGEN INC [US], et al) [PDA] 1-90 * the whole document *;
 [X]  - DUNCAN M R ET AL, "CONNECTIVE TISSUE GROWTH FACTOR MEDIATES TRANSFORMING GROWTH FACTORBETA-INDUCED COLLAGEN SYNTHESIS: DOWN REGULATION BY CAMP", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, (1999), vol. 13, no. 13, ISSN 0892-6638, pages 1774 - 1786, XP000916666 [X] 1-26,29,51-79 * the whole document *
 [PX]  - USINGER WILLIAM R ET AL, "TGFbeta2 binds CTGF specifically and is inhibited by a CTGF neutralizing antibody, FG-3019.", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, & MEETING OF THE AMERICAN SOCIETY OF NEPHROLOGY RENAL WEEK; SAN DIEGO, CA, USA; NOVEMBER 12-17, 2003, (200311), vol. 14, no. Abstracts Issue, ISSN 1046-6673, page 374A, XP009041082 [PX] 1-90 * abstract *
 [PA]  - LAM SUZANNE ET AL, "Connective tissue growth factor and IGF-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose.", DIABETES, (200312), vol. 52, no. 12, ISSN 0012-1797, pages 2975 - 2983, XP002310287 [PA] 1-90 * the whole document *

DOI:   http://dx.doi.org/10.2337/diabetes.52.12.2975
ExaminationWO03024308
otherWO03024308
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.